{"article": [{"url": "https://www.marketwatch.com/story/goodrx-to-sell-up-to-9692-million-worth-of-shares-in-ipo-2020-09-14", "published": 1600067060.0, "headline": "GoodRx to sell up to $969.2 million worth of shares in IPO", "body": "GoodRx Holdings Inc. set terms for its initial public offering, as the California-based telehealth company is looking to sell up to $969.2 million worth of Class A shares. The offering includes 23.4 million shares offered by the company and 11.2 million shares offered by selling stockholders, with the IPO expected to price between $24 and $28 a share. The shares are expected to trade on the Nasdaq under the ticker symbol \"GDRX.\" There will be 38.5 million Class A shares outstanding after the IPO and 345.6 million Class B shares, with Class A shareholders entitled to 1 vote and Class B shareholders entitled to 10 votes and convertible into one Class A share. Morgan Stanley, Goldman Sachs, J.P. Morgan and Barclays are the lead underwriters. For the six months ended June 30, GoodRx recorded net income of $54.7 million revenue of $256.7 million, after net income of $31.2 million on revenue of $173.2 million a year ago. The company is looking to go public at a good time for IPOs, with the Renaissance IPO ETF IPO, +1.98% rallying 27.1% over the past three months and the S&P 500 SPX, +0.87% advancing 9.9%."}]}